Japan
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.06 B
|
March 31, 2024 | USD 9.46 | 1.16% |
|
Japan |
|
2 |
USD 8.10 M
|
Dec. 31, 2023 | USD 3.66 | 1.69% |
|
Japan |
|
3 |
USD 5.62 M
|
Dec. 31, 2023 | USD 2.65 | 4.67% |
|
Japan |
|
4 |
USD 4.82 M
|
Dec. 31, 2023 | USD 1.21 | 0.22% |
|
Japan |
|
5 |
USD 4.57 M
|
March 31, 2024 | USD 0.28 | 0.77% |
|
Japan |
|
6 |
USD 4.44 M
|
March 31, 2024 | USD 0.17 | 4.80% |
|
Japan |
|
7 |
USD 1.87 M
|
Dec. 31, 2023 | USD 13.30 | 2.22% |
|
Japan |
|
8 |
USD 24.63 K
|
March 31, 2024 | USD 0.93 | 0.77% |
|
Japan |
|
9 |
USD -1.62 M
|
June 30, 2024 | USD 1.00 | 0.77% |
|
Japan |
|
10 |
USD -8.21 M
|
March 31, 2024 | USD 11.55 | 2.65% |
|
Japan |
|
11 |
USD -13.42 M
|
March 31, 2024 | USD 3.30 | 4.32% |
|
Japan |
|
12 |
USD -16.87 M
|
Dec. 31, 2023 | USD 9.92 | 1.44% |
|
Japan |
|
13 |
USD -66.11 M
|
March 31, 2024 | USD 24.56 | 1.18% |
|
Japan |
|
14 |
USD -224.84 M
|
March 31, 2024 | USD 9.63 | -2.79% |
|
Japan |
|
15 |
USD -838.12 M
|
March 31, 2024 | USD 14.57 | 3.59% |
|
Japan |
The Vaccines company in Japan with the highest Net Cash Used Provided By Financing Activities is Astellas Pharma Inc. (Tokyo Stock Exchange: 4503.T) at USD 4.06 B.
The Vaccines company in Japan with the lowest Net Cash Used Provided By Financing Activities is Shionogi & Co., Ltd. (Tokyo Stock Exchange: 4507.T) at USD -838.12 M.
The top 10 Vaccines companies in Japan by Net Cash Used Provided By Financing Activities are Astellas Pharma Inc., Oncolys BioPharma Inc., RaQualia Pharma Inc., SymBio Pharmaceuticals Limited, BrightPath Biotherapeutics Co., Ltd., OncoTherapy Science, Inc., PeptiDream Inc., NanoCarrier Co., Ltd., Soiken Holdings Inc. and WDB Holdings Co., Ltd..
The bottom 10 Vaccines companies in Japan by Net Cash Used Provided By Financing Activities are Shionogi & Co., Ltd., Santen Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Mizuho Medy Co.,Ltd., JCR Pharmaceuticals Co., Ltd., WDB Holdings Co., Ltd., Soiken Holdings Inc., NanoCarrier Co., Ltd., PeptiDream Inc. and OncoTherapy Science, Inc..